Follow
Lu Tian
Lu Tian
Verified email at stanford.edu
Title
Cited by
Cited by
Year
Discovering statistically significant pathways in expression profiling studies
L Tian, SA Greenberg, SW Kong, J Altschuler, IS Kohane, PJ Park
Proceedings of the National Academy of Sciences 102 (38), 13544-13549, 2005
8232005
Sex modifies the APOE‐related risk of developing Alzheimer disease
A Altmann, L Tian, VW Henderson, MD Greicius, ...
Annals of neurology 75 (4), 563-573, 2014
7982014
Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis
H Uno, B Claggett, L Tian, E Inoue, P Gallo, T Miyata, D Schrag, ...
Journal of clinical Oncology 32 (22), 2380, 2014
6282014
Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation
T Thenappan, SJ Shah, S Rich, L Tian, SL Archer, M Gomberg-Maitland
European Respiratory Journal 35 (5), 1079-1087, 2010
5192010
The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease
T Shirai, RR Nazarewicz, BB Wallis, RE Yanes, R Watanabe, M Hilhorst, ...
Journal of Experimental Medicine 213 (3), 337-354, 2016
4462016
A simple method for estimating interactions between a treatment and a large number of covariates
L Tian, AA Alizadeh, AJ Gentles, R Tibshirani
Journal of the American Statistical Association 109 (508), 1517-1532, 2014
4242014
Narrative review: assessment of C-reactive protein in risk prediction for cardiovascular disease
DM Lloyd-Jones, K Liu, L Tian, P Greenland
Annals of internal medicine 145 (1), 35-42, 2006
3972006
Evaluating Prediction Rules for t-Year Survivors With Censored Regression Models
H Uno, T Cai, L Tian, LJ Wei
Journal of the American Statistical Association 102 (478), 527-537, 2007
3892007
A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data
H Uno, L Tian, T Cai, IS Kohane, LJ Wei
Statistics in medicine 32 (14), 2430-2442, 2013
3372013
Physical activity during daily life and mortality in patients with peripheral arterial disease
PK Garg, L Tian, MH Criqui, K Liu, L Ferrucci, JM Guralnik, J Tan, ...
Circulation 114 (3), 242-248, 2006
3062006
Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial
MM McDermott, K Liu, JM Guralnik, MH Criqui, B Spring, L Tian, ...
Jama 310 (1), 57-65, 2013
3052013
Asymptomatic peripheral arterial disease is associated with more adverse lower extremity characteristics than intermittent claudication
MM McDermott, JM Guralnik, L Ferrucci, L Tian, K Liu, Y Liao, D Green, ...
Circulation 117 (19), 2484-2491, 2008
296*2008
On the Cox model with time-varying regression coefficients
L Tian, D Zucker, LJ Wei
Journal of the American statistical Association 100 (469), 172-183, 2005
2862005
AKI in hospitalized children: epidemiology and clinical associations in a national cohort
SM Sutherland, J Ji, FH Sheikhi, E Widen, L Tian, SR Alexander, XB Ling
Clinical journal of the American Society of Nephrology 8 (10), 1661-1669, 2013
2812013
Analysis of randomized comparative clinical trial data for personalized treatment selections
T Cai, L Tian, PH Wong, LJ Wei
Biostatistics 12 (2), 270-282, 2011
2702011
Associations of borderline and low normal ankle-brachial index values with functional decline at 5-year follow-up: the WALCS (Walking and Leg Circulation Study)
MM McDermott, JM Guralnik, L Tian, K Liu, L Ferrucci, Y Liao, L Sharma, ...
Journal of the American College of Cardiology 53 (12), 1056-1062, 2009
2492009
Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis
Z Yang, Y Shen, H Oishi, EL Matteson, L Tian, JJ Goronzy, CM Weyand
Science translational medicine 8 (331), 331ra38-331ra38, 2016
2412016
On the restricted mean survival time curve in survival analysis
L Zhao, B Claggett, L Tian, H Uno, MA Pfeffer, SD Solomon, L Trippa, ...
Biometrics 72 (1), 215-221, 2016
2252016
Effectively selecting a target population for a future comparative study
L Zhao, L Tian, T Cai, B Claggett, LJ Wei
Journal of the American Statistical Association 108 (502), 527-539, 2013
2172013
Interpretability of cancer clinical trial results using restricted mean survival time as an alternative to the hazard ratio
K Pak, H Uno, DH Kim, L Tian, RC Kane, M Takeuchi, H Fu, B Claggett, ...
JAMA oncology 3 (12), 1692-1696, 2017
2132017
The system can't perform the operation now. Try again later.
Articles 1–20